Gan to kagaku ryoho. Cancer & chemotherapy 1997-01-01

[Anti tumor activity of farnesyl transferase inhibitor].

K Yoshimatsu, T Nagasu

Index: Gan To Kagaku Ryoho. 24(2) , 145-55, (1997)

Full Text: HTML

Abstract

Posttranslational farnesylation by farnesyltransferase (FTase) is critical for the function of ras oncogene product and FTase has attracted attention as the new target of anticancer agents. B956 and B1352, obtained from the screening of CAAX analog inhibitors of FTase, induced flat reversion and inhibited the anchorage independent growth of ras transformant and ras mutated human tumor cell lines through the inhibition of posttranslational modification of ras p21. Inhibition of tumor growth in vivo was caused by inhibition of ras processing. Methyl ester prodrug of B956 and B1352 showed antitumor activity in ras mutated human tumor xenograft model. FTase inhibitor has the potential to be developed as therapy for ras mutated human tumors.

Related Compounds

  • FTase Inhibitor...

Related Articles:

Bcl-2 differentially targets K-, N-, and H-Ras to mitochondria in IL-2 supplemented or deprived cells: implications in prevention of apoptosis.

1999-09-02

[Oncogene 18(35) , 4930-9, (1999)]

Peptidomimetic inhibitors of Ras farnesylation and function in whole cells.

1993-09-05

[J. Biol. Chem. 268(25) , 18415-8, (1993)]

Insulin regulation of glucose-6-phosphate dehydrogenase gene expression is rapamycin-sensitive and requires phosphatidylinositol 3-kinase.

1998-06-12

[J. Biol. Chem. 273(24) , 14968-74, (1998)]

A role for Ras in v-Crk transformation.

1996-11-01

[Cell Growth Differ. 7(11) , 1443-51, (1996)]

Activation of the store-operated calcium current ICRAC can be dissociated from regulated exocytosis in rat basophilic leukaemia (RBL-1) cells.

2003-12-01

[J. Physiol. 553(Pt 2) , 387-93, (2003)]

More Articles...